High Five for Low Five [0.03%]
五指庆功拳
Roger E G Schutgens
Roger E G Schutgens
Measuring Clinical Benefit of Treatments for Hematologic Malignancies: Critical First Steps Accomplished-What is Next? [0.03%]
血液系统恶性肿瘤治疗临床疗效评价：已迈出关键第一步，未来任重道远
John G Gribben,Elisabeth de Vries,Nathan I Cherny et al.
John G Gribben et al.
John Gribben,Elizabeth Macintyre,Pieter Sonneveld et al.
John Gribben et al.
EHA Endorsement of ESMO Clinical Practice Guidelines for Marginal Zone Lymphomas [0.03%]
欧洲血液学协会对边缘区淋巴瘤的ESMO临床实践指南的认同
Marco Ladetto,Martin Dreyling
Marco Ladetto
Beyond DNA Damage: Exploring the Immunomodulatory Effects of Cyclophosphamide in Multiple Myeloma [0.03%]
超越DNA损伤：探讨环磷酰胺在多发性骨髓瘤中免疫调节作用的探索
Dawn Swan,Mark Gurney,Janusz Krawczyk et al.
Dawn Swan et al.
The alkylating agent cyclophosphamide has been used in the treatment of multiple myeloma for over 60 years. At low doses, cyclophosphamide also has significant immunomodulatory activity, which can be used to modify the immunosuppressive tum...
David Kent
David Kent
CD56dimCD16dim Natural Killer (NK) Cells: The Forgotten Population [0.03%]
低CD16表达的CD56(dim)自然杀伤(NK)细胞：被遗忘的群体
Jacques Zimmer
Jacques Zimmer
Droplet Digital PCR Quantification of Mantle Cell Lymphoma Follow-up Samples From Four Prospective Trials of the European MCL Network [0.03%]
欧洲MCL网络四项前瞻性试验的套细胞淋巴瘤随访样本的液滴数字PCR检测
Daniela Drandi,Marion Alcantara,Ichrafe Benmaad et al.
Daniela Drandi et al.
Minimal residual disease (MRD) has been increasingly investigated in mantle cell lymphoma (MCL), including for individual therapeutic stratification and pre-emptive treatment in clinical trials. Although patient/allele specific real-time qu...
Clinical Significance of TARP Expression in Pediatric Acute Myeloid Leukemia [0.03%]
TARP表达在儿童急性髓系白血病中的临床意义
Barbara Depreter,Barbara De Moerloose,Karl Vandepoele et al.
Barbara Depreter et al.
Allogeneic Hematopoietic Cell Transplantation in Patients With Aplastic Anemia and Paroxysmal Nocturnal Hemoglobinuria Clones: Time for a Change [0.03%]
骨髓增生异常综合征患者进行allo-HSCT的预后因素分析：单中心经验
Eleni Gavriilaki,Ioanna Sakellari,Despina Mallouri et al.
Eleni Gavriilaki et al.